Status:
UNKNOWN
Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)
Lead Sponsor:
Hannover Medical School
Conditions:
Dupuytren Contracture
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
Dupuytren's disease is a progressive disease due to unknown causal agents or genetics. Dupuytren's disease contains nodules and cords in the fascia as the epicenter of disease progression. Nodules co...
Eligibility Criteria
Inclusion
- Eligible patients are patients aged 18 or over and 80 or younger
- Dupuytren's disease of stage 1-4 involving one or more fingers or the palm only
Exclusion
- Exclusion criteria are suspected or evident pregnancy
- no Dupuytren's disease
- evident ulcerations
- no informed consent
- age under 18 years or above 80 years.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01184586
Start Date
November 1 2011
End Date
December 1 2012
Last Update
December 2 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hannover Medical School, Plastic, Hand and Reconstructive Surgery
Hanover, Germany, 30625